The abstract is read at the publisher; the summary is JClub's.
A conserved HUWE1 C-terminal phospho-degron on ASCL1 centered on Ser207 and terminal Trp/Phe residues is required for HUWE1 docking and ubiquitin-mediated degradation in small cell lung cancer.
- Why it matters: Lineage transcription factors like ASCL1 are hard to drug, and the substrate-recognition rules of large HECT ubiquitin ligases are incompletely defined, limiting targeted degradation strategies.
- What they did: The study used genome-wide CRISPR knockout screening and base editor tiling screens at amino acid resolution, both with an endogenous knock-in ASCL1 reporter, to map degradation determinants and HUWE1 regulatory features.
- The result: HUWE1 is identified as the dominant regulator of ASCL1 stability in SCLC, and an autoinhibitory negatively charged helix gates phospho-degron access; charge-flipping mutations accelerate degradation of ASCL1 and DDIT4 and destabilizing ASCL1 impairs SCLC proliferation.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.